2 years ago
CRBP
AnalystsJeff JonesJeff Jones's Stock Forecasts
AnalystsJeff Jones
Analyst Ranking
Top 13%
#654 out of 5116 analysts
Average Return
+14.56%
Win Rate
38%40 out of 105
Risk vs Reward
Poor
Good
Jeff Jones's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | +771.54% | $6.15 | $53.60 | 2023-08-09 - 2024-08-08 | Buy |
Fusion Pharmaceuticals IncFUSN | +728.85% | $2.60 | $21.55 | 2023-09-29 - 2024-06-03 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +369.82% | $9.31 | $43.74 | 2023-05-10 - 2024-05-09 | Buy |
Ventyx Biosciences IncVTYX | +298.64% | $2.20 | $8.77 | 2024-11-08 - 2025-11-07 | Buy |
Prometheus Biosciences IncRXDX | +235.61% | $59.57 | $199.92 | 2022-10-04 - 2023-06-15 | Buy |
Jeff Jones Analyst Color
Get additional color on Jeff Jones's coverage of popular stocks
Jeff Jones's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pelthos Therapeutics IncPTHS | 2 | Buy | $57.00 | +100.70% | Reiterates | 15 days ago |
Ventyx Biosciences IncVTYX | 10 | Buy | $14.00 | +40.00% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 6 | Buy | $63.00 | -7.19% | Maintains | 2 months ago |
Chemomab Therapeutics LtdCMMB | 7 | Buy | $25.00 | +854.20% | Maintains | 3 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 10 | Buy | $53.00 | +359.27% | Maintains | 4 months ago |
Arrivent Biopharma IncAVBP | 3 | Buy | $44.00 | +91.80% | Maintains | 5 months ago |
Y Mabs Therapeutics IncYMAB | 4 | Buy | $15.00 | +74.22% | Maintains | 6 months ago |
Alumis IncALMS | 3 | Buy | $25.00 | +225.95% | Maintains | 6 months ago |
Zura Bio LtdZURA | 4 | Buy | $17.00 | +342.71% | Maintains | 7 months ago |
Corvus Pharmaceuticals IncCRVS | 5 | Buy | $17.00 | +85.39% | Reiterates | 7 months ago |
Immunocore Holdings PLCIMCR | 2 | Buy | $86.00 | +117.72% | Maintains | 7 months ago |
Evolent Health IncEVH | 4 | Buy | $18.00 | +328.57% | Maintains | 10 months ago |
Perspective Therapeutics IncCATX | 6 | Buy | $16.00 | N/A | Maintains | a year ago |
Cellectar Biosciences IncCLRB | 4 | Buy | $360.00 | N/A | Maintains | a year ago |
Pliant Therapeutics IncPLRX | 6 | Buy | $45.00 | N/A | Maintains | a year ago |
Seres Therapeutics IncMCRB | 3 | Buy | $80.00 | N/A | Maintains | 2 years ago |
Patterson Companies IncPDCO | 3 | Hold | $30.00 | N/A | Maintains | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Buy | $15.00 | N/A | Maintains | 2 years ago |
Bio Green Med Solution IncBGMS | 3 | Buy | $28,800.00 | N/A | Maintains | 3 years ago |
Point Biopharma Global IncPNT | 2 | Buy | $13.00 | N/A | Reiterates | 3 years ago |
Novan IncNOVNQ | 2 | Buy | $8.00 | N/A | Maintains | 3 years ago |
Pmv Pharmaceuticals IncPMVP | 5 | Buy | $15.00 | N/A | Reiterates | 3 years ago |
An2 Therapeutics IncANTX | 1 | Buy | $24.00 | N/A | Maintains | 3 years ago |
Moleculin Biotech IncMBRX | 2 | Buy | $75.00 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Buy | $150.00 | N/A | Maintains | 3 years ago |
Evaxion AEVAX | 2 | Buy | $1,100.00 | N/A | Maintains | 3 years ago |
Notable Labs LtdNTBLQ | 1 | Buy | $5.50 | N/A | Assumes | 3 years ago |
Rain Oncology IncRAIN2 | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.